Dafeng Yang
Impact in
- Immunology top 5%
- Immune cells in cancer
- Molecular Biology top 5%
- Chromatin Remodeling and Cancer
- DNA Repair Mechanisms
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Cell death mechanisms and regulation
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 8
-
- MicroRNA in disease regulation 3
- NF-κB Signaling Pathways 2
- Co-authors
- Kebin Liu (43 shared papers)Weidong Wang (5 shared papers)Chunwan Lu (20 shared papers)John David Klement (20 shared papers)Yutong Xue (4 shared papers)Priscilla S. Redd (13 shared papers)Sharleen Zhou (3 shared papers)Amy V. Paschall (9 shared papers)
- Journals
- Cancer Research (7 papers)The Journal of Immunology (6 papers)Journal for ImmunoTherapy of Cancer (4 papers)BMC Cancer (3 papers)The FASEB Journal (3 papers)
- Partner nations
- United StatesChinaIreland
In The Last Decade
Dafeng Yang
73 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 79
- Immunology 447
- Molecular Biology 1.2k
- Cancer Research 234
- Oncology 343
- Pulmonary and Respiratory Medicine 215
Countries citing papers authored by Dafeng Yang
This map shows the geographic impact of Dafeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafeng Yang more than expected).
Fields of papers citing papers by Dafeng Yang
This network shows the impact of papers produced by Dafeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafeng Yang. The network helps show where Dafeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dafeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 310 | |
| 2 | 2003 | 285 | |
| 3 | 2018 | 280 | |
| 4 | 2000 | 257 | |
| 5 | 1998 | 245 | |
| 6 | 2000 | 234 | |
| 7 | 2012 | 128 | |
| 8 | 2020 | 125 | |
| 9 | 2021 | 114 | |
| 10 | 2020 | 112 | |
| 11 | 2015 | 98 | |
| 12 | 2023 | 94 | |
| 13 | 2018 | 81 | |
| 14 | 2007 | 80 | |
| 15 | 2012 | 77 | |
| 16 | 2003 | 76 | |
| 17 | 2021 | 72 | |
| 18 | 2020 | 69 | |
| 19 | 2017 | 68 | |
| 20 | 2017 | 64 |
About Dafeng Yang
Dafeng Yang is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Clinical Biochemistry, having authored 75 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Epigenetics and DNA Methylation (5 papers), Cell death mechanisms and regulation (5 papers), Immune cells in cancer (4 papers), Chromatin Remodeling and Cancer (4 papers), MicroRNA in disease regulation (3 papers), Advanced Glycation End Products research (3 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Immunology (447 citations), Molecular Biology (1.2k citations), Cancer Research (234 citations), Oncology (343 citations) and Pulmonary and Respiratory Medicine (215 citations). Dafeng Yang has collaborated with scholars based in United States, China and Ireland. Frequent co-authors include Kebin Liu, Weidong Wang, Chunwan Lu, John David Klement, Yutong Xue, Priscilla S. Redd, Sharleen Zhou, Amy V. Paschall, Salvatore Sechi and Zuqin Nie. Their work appears in journals such as Cancer Research, The Journal of Immunology, Journal for ImmunoTherapy of Cancer, BMC Cancer and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.